Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04212871 · ClinicalTrials.gov registry record · NA
The Effect of Mukbang on the Desire to Eat
A NA study of Mukbang, sponsored by Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 520
- Enrollment target
- 1
- Study location
NCT04212871: Completed NA study of Mukbang, sponsored by Cornell University.
NCT04212871 is a NA study of Mukbang that has completed, run by Cornell University. The registered enrollment target is 520 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04212871, a NA study of Mukbang, has completed, sponsored by Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 520 participants
- Enrollment target
- 1
- Study location
Study Summary
Mukbang is an online eating broadcast where a host (Asian mukbangs generally feature a young and slim female host) consumes a large amount of food while chatting with audiences. Since some dieters watch mukbang to get satiation and control their appetites, the current study is aimed at testing the effect of mukbang on the desire to eat. Two randomized and controlled trails are conducted. The first randomized and controlled trail is conducted online using the Amazon Mturk. Participants (n=286) were randomly assigned to watch one of the following 3 videos: ramen mukbang (n=98), donut mukbang (n=97) and a non-food content video (n=91). The other study is a in person study. Participants (n=234) were randomly assigned to watch one of the following 3 videos: hotpot mukbang (n=79), hotpot cooking show (n=76) and a non-food content video (n=79). The investigators used the self-report survey to test whether the mukbang affects the desire to eat, and participants' satiation and disgust.
Primary Outcome
participants evaluate their satiation level on a scale from -3 to 3. -3 means not satisfied at all, 3 means very satsfied.
Conditions Studied
Interventions
- OTHER watch food video 1
- OTHER watch food video 2
- OTHER watch a non-food content video
Study Locations (1)
New York
- Cornell University - Ithaca
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 520 participants |
| Start Date | 2019-01-12 |
| Est. Completion | 2019-04-01 |
| Phase | NA |
What the finished NCT04212871 record still lists
NCT04212871 is an interventional study that assigns participants to a tested intervention. The registered 520 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Mukbang appearing as the primary indexed condition, and to 3 interventions - of which watch food video 1 is the first listed.
NCT04212871 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04212871 about?
NCT04212871 is a clinical study titled "The Effect of Mukbang on the Desire to Eat". Mukbang is an online eating broadcast where a host (Asian mukbangs generally feature a young and slim female host) consumes a large amount of food while chatting with audiences. Since some dieters watch mukbang to get satiation and control their appetites, the current study is aimed at testing the e...
What is the current status of trial NCT04212871?
This trial is currently completed. It is a NA study. The enrollment target is 520 participants. The study started on 2019-01-12. Estimated completion is 2019-04-01.
What conditions does trial NCT04212871 study?
This clinical trial studies the following conditions: Mukbang.
What interventions are being tested in trial NCT04212871?
The interventions under investigation include: watch food video 1 (OTHER), watch food video 2 (OTHER), watch a non-food content video (OTHER).
Who is sponsoring clinical trial NCT04212871?
This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04212871 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04212871's enrollment target sits among peer trials
520 190th of 2000 higher than 1,810 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323581 · 520 participants · NA
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
- NCT04656496 · 520 participants · NA
NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors
- NCT05445778 · 520 participants · Phase 3
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
- NCT05498428 · 520 participants · Phase 2
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI